The association between circulating angiotensin-converting enzyme and cardiovascular risk in the elderly: A cross-sectional study

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 12, Issue 3, 2011, Pages 281-289

  Ljungberg, Liza ^a   Alehagen, Urban ^a   Länne, Toste ^a   Björck, Hanna ^a   De Basso, Rachel ^a   Dahlström, Ulf ^a   Persson, Karin ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Cardiovascular risk factors; diabetes; endothelium; genetics; smoking

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

AGED; ARTICLE; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL ELECTROPHORESIS; GENETIC POLYMORPHISM; GENOTYPE; GERIATRIC PATIENT; HEART MUSCLE ISCHEMIA; HEREDITY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; SMOKING;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDEL MUTATION; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS; SWEDEN;

EID: 80051664448     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320310391326     Document Type: Article

References (37)

1. Cambien F., Costerousse O., Tiret L., et al. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994 ; 90: 669-676. (Pubitemid 24242731)
2. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P. and Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990 ; 86: 1343-1346. (Pubitemid 20370444)
3. Cambien F., Poirier O., Lecerf L., et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992 ; 359: 641-644.
4. Mattu RK, Needham EW, Galton DJ, Frangos E., Clark AJ and Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation 1995 ; 91: 270-274.
5. Kario K., Hoshide S., Umeda Y., et al. Angiotensinogen and angiotensin-converting enzyme genotypes, and day and night blood pressures in elderly Japanese hypertensives. Hypertens Res 1999 ; 22: 95-103. (Pubitemid 29371682)
6. Schunkert H., Hense HW, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994 ; 330: 1634-1638.
7. Harrap SB, Tzourio C., Cambien F., et al. The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition. Hypertension 2003 ; 42: 297-303. (Pubitemid 37093476)
8. Lindpaintner K., Pfeffer MA, Kreutz R., et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995 ; 332: 706-711.
9. Nordestgaard BG, Kontula K., Benn M., et al. Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the LIFE study. Pharmacogenet Genomics 2010 ; 20: 77-85.
10. Sagnella GA, Rothwell MJ, Onipinla AK, Wicks PD, Cook DG and Cappuccio FP A population study of ethnic variations in the angiotensin-converting enzyme I/D polymorphism: relationships with gender, hypertension and impaired glucose metabolism. J Hypertens 1999 ; 17: 657-664. (Pubitemid 29243498)
11. Bloem LJ, Manatunga AK and Pratt JH Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity. Hypertension. 1996 ; 27: 62-66. (Pubitemid 26017682)
12. Petrovic D., Bregar D., Guzic-Salobir B., et al. Sex difference in the effect of ACE-DD genotype on the risk of premature myocardial infarction. Angiology 2004 ; 55: 155-158. (Pubitemid 38337747)
13. Zhu X., Bouzekri N., Southam L., et al. Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet 2001 ; 68: 1139-1148. (Pubitemid 32424413)
14. Zhu X., McKenzie CA, Forrester T., et al. Localization of a small genomic region associated with elevated ACE. Am J Hum Genet. 2000 ; 67: 1144-1153.
15. McKenzie CA, Zhu X., Forrester TE, et al. A genome-wide search replicates evidence of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE) unlinked to the ACE gene. BMC Med Genomics 2008 ; 1: 23.
16. Gallagher PE, Li P., Lenhart JR, Chappell MC and Brosnihan KB Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension 1999 ; 33: 323-328. (Pubitemid 29065679)
17. Saijonmaa O., Nyman T., Kosonen R. and Fyhrquist F. Upregulation of angiotensin-converting enzyme by vascular endothelial growth factor. Am J Physiol Heart Circ Physiol 2001 ; 280: H885 - H891.
18. Hilgenfeldt U., Puschner T., Riester U., Finsterle J., Hilgenfeldt J. and Ritz E. Low-salt diet downregulates plasma but not tissue kallikrein-kinin system. Am J Physiol 1998 ; 275: F88 - F93.
19. Ueda S., Heeley RP, Lees KR, Elliott HL and Connell JM Mistyping of the human angiotensin-converting enzyme gene polymorphism: frequency, causes and possible methods to avoid errors in typing. J Mol Endocrinol 1996 ; 17: 27-30. (Pubitemid 26258898)
20. Ljungberg LU and Persson K. Effect of nicotine and nicotine metabolites on Angiotensin-converting enzyme in human endothelial cells. Endothelium. 2008 ; 15: 239-245.
21. Gaertner R., Prunier F., Philippe M., Louedec L., Mercadier JJ and Michel JB Scar and pulmonary expression and shedding of ACE in rat myocardial infarction. Am J Physiol Heart Circ Physiol 2002 ; 283: H156 - H164. (Pubitemid 34705335)
22. Oppong SY and Hooper NM Characterization of a secretase activity which releases angiotensin-converting enzyme from the membrane. Biochem J 1993 ; 292: 597-603. (Pubitemid 23181980)
23. Kleinbongard P., Dejam A., Lauer T., et al. Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans. Free Radic Biol Med 2006 ; 40: 295-302. (Pubitemid 43069353)
24. Mizuno K., Yaginuma K., Hashimoto S., Toki T., Nakamura I. and Fukuchi S. Acute effect of cigarette smoking on serum angiotensin-converting enzyme activity in normal man. Tohoku J Exp Med 1982 ; 137: 113-114. (Pubitemid 12068272)
25. Sugiyama Y., Yotsumoto H. and Takaku F. Increase of serum angiotensin-converting enzyme level after exposure to cigarette smoke and nicotine infusion in dogs. Respiration 1986 ; 49: 292-295. (Pubitemid 16138258)
26. Ninomiya Y., Kioi S. and Arakawa M. Serum angiotensin converting enzyme activity in ex-smokers. Clin Chim Acta 1987 ; 164: 223-226. (Pubitemid 17070538)
27. Haboubi NA, Bignell AH and Haboubi NY Serum angiotensin converting enzyme activity in cigarette smokers. Clin Chim Acta 1986 ; 154: 69-72. (Pubitemid 16163437)
28. Ng DP, Tai BC, Koh D., Tan KW and Chia KS Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia 2005 ; 48: 1008-1016. (Pubitemid 40767996)
29. Dalla Vestra M., Simioni N. and Masiero A. Renal effects of dual renin-angiotensin-aldosterone system blockade in patients with diabetic nephropathy. Int Urol Nephrol 2009 ; 41: 119-126.
30. Toop MJ, Dallinger KJ, Jennings PE and Barnett AH Angiotensin-converting enzyme (ACE): relationship to insulin-dependent diabetes and microangiopathy. Diabet Med 1986 ; 3: 455-457. (Pubitemid 16030509)
31. Van Dyk DJ, Erman A., Erman T., Chen-Gal B., Sulkes J. and Boner G. Increased serum angiotensin converting enzyme activity in type I insulin-dependent diabetes mellitus: its relation to metabolic control and diabetic complications. Eur J Clin Invest 1994 ; 24: 463-467. (Pubitemid 24232619)
32. Yusuf S., Gerstein H., Hoogwerf B., et al. Ramipril and the development of diabetes. JAMA 2001 ; 286: 1882-1885. (Pubitemid 33010241)
33. Hoeper MM, Tacacs A., Stellmacher U. and Lichtinghagen R. Lack of association between angiotensin converting enzyme (ACE) genotype, serum ACE activity, and haemodynamics in patients with primary pulmonary hypertension. Heart 2003 ; 89: 445-446. (Pubitemid 36379422)
34. Schunkert H., Hense HW, Muscholl M., Luchner A. and Riegger GA Association of angiotensin converting enzyme activity and arterial blood pressure in a population-based sample. J Hypertens 1996 ; 14: 571-575. (Pubitemid 26161111)
35. Erman A., Chen-Gal B., van Dijk DJ, et al. Ovarian angiotensin-converting enzyme activity in humans: relationship to estradiol, age, and uterine pathology. J Clin Endocrinol Metab 1996 ; 81: 1104-1107. (Pubitemid 26083977)
36. Dux S., Aron N., Boner G., Carmel A., Yaron A. and Rosenfeld JB Serum angiotensin converting enzyme activity in normal adults and patients with different types of hypertension. Isr J Med Sci 1984 ; 20: 1138-1142. (Pubitemid 15199010)
37. Keavney B., McKenzie C., Parish S., et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet 2000 ; 355: 434-442. (Pubitemid 30085151)